A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT02853565 · COMPLETED
Trial details
- NCT number
- NCT02853565
- Sponsor
- CANbridge Life Sciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.